AMERIPRISE FINANCIAL INC - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 241 filers reported holding EDITAS MEDICINE INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q3 2023$103,087
-34.9%
13,216
-31.3%
0.00%
Q2 2023$158,427
-62.6%
19,250
-67.1%
0.00%
Q1 2023$424,052
-75.4%
58,490
-69.9%
0.00%
-100.0%
Q4 2022$1,723,000
-29.8%
194,259
-3.1%
0.00%0.0%
Q3 2022$2,454,000
+355.3%
200,534
+339.5%
0.00%
Q2 2022$539,000
-40.0%
45,628
-3.4%
0.00%
Q1 2022$898,000
-35.7%
47,216
-10.1%
0.00%
Q4 2021$1,396,000
-3.9%
52,513
+48.5%
0.00%
Q3 2021$1,453,000
-47.9%
35,369
-28.2%
0.00%
-100.0%
Q2 2021$2,789,000
+79.5%
49,231
+33.1%
0.00%0.0%
Q1 2021$1,554,000
-7.1%
36,982
+45.9%
0.00%0.0%
Q4 2020$1,673,000
+441.4%
25,343
+129.4%
0.00%
Q3 2020$309,000
-25.4%
11,049
-21.4%
0.00%
Q2 2020$414,000
-6.8%
14,059
-37.2%
0.00%
Q1 2020$444,000
-71.2%
22,381
-57.0%
0.00%
-100.0%
Q4 2019$1,540,000
-4.8%
52,007
-26.9%
0.00%0.0%
Q3 2019$1,617,000
+21.9%
71,116
+32.7%
0.00%0.0%
Q2 2019$1,326,000
-16.2%
53,594
-17.2%
0.00%0.0%
Q1 2019$1,582,000
+42.4%
64,708
+32.5%
0.00%0.0%
Q4 2018$1,111,000
-36.1%
48,843
-10.7%
0.00%0.0%
Q3 2018$1,740,000
+44.6%
54,670
+62.8%
0.00%0.0%
Q2 2018$1,203,000
+107.4%
33,573
+69.5%
0.00%
Q1 2018$580,00019,8040.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q3 2020
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders